Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer
Clinical trial NCT02020291 · COMPLETED
Trial details
- NCT number
- NCT02020291
- Sponsor
- WntResearch AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.